 |
|
Samtheo Biopharma LLC (“Samtheo”) is a privately-held company that invests in biotechnology companies that focus on the delivery of personalized medicine through targeted therapeutics. Samtheo is in the business of:
|
 |
- (1) acquisition
- (2) development
- (3) commercialization
|
|
|
of innovative technology "with integrity", i.e. proprietary, novel intellectual property that will generate evidence-based, medically effective and socially-assessable products. Samtheo's global mission is to improve health care and outcomes dramatically for patients with life-threatening diseases and unmet medical needs.
|
|
READ MORE
|
|
 |
 |
 |
Susan Rosenbaum, Esq.
Co-Founder, Chairman and Chief Executive Officer
- Corporate Lawyer, Investment Banker, Executive Officer
- Over 30 years Legal and Business Experience
- Expertise in National and International Corporate Development and Business Development
- Served as Director and Officer of Public and Private Corporations
- Consultant on Medical Research Proposals, Journal Articles and Educational Lectures
- National and International Speaker and Author
Lawrence Akinsanmi, M.D., Ph.D.
Co-Founder, President and Chief Operations Officer
- M.D. Internal Medicine (Oncologist)
- Ph.D. Clinical Pharmacologist
- Over 20 years Experience in Drug Development
- Strong Knowledge of Pre-Clinical and Clinical Drug Development
- Successful US and Global Drug Approvals
- Small and Large Company Experience
|
|
